We have located links that may give you full text access.
Journal Article
Review
Assisted reproductive technology: Impact on society and need for surveillance.
Best Practice & Research. Clinical Endocrinology & Metabolism 2019 January 26
Since the first successful treatment with conventional in vitro fertilization (IVF) in 1978 assisted reproductive technology (ART) has become an integral part of modern medicine and now plays a key role in the fulfillment of family planning. At least five million of infants have been born as a result of ART and in some countries the proportion of infants born after ART now exceeds 5%. Such an impact of ART on society and demography call for adequate surveillance including vigilance of occurring adverse events, especially when novel technology is introduced. In many countries the activities in ART are being recorded and analyzed by national registries, either on a voluntary or on a compulsory basis. Despite all endeavour, the data sets are still incomplete and complications are underreported. In addition, the published reports usually contain cross-sectional data only, collected and analyzed on an annual basis. However, current ART is now developing towards a segmented longitudinal approach, in which single therapeutic steps may be spread over prolonged time intervals. In the near future, ART-data should be handled and reported in a cumulative fashion. The final outcome of ART, defined by the birth of a healthy baby or by the final consumption or destruction of cells and tissues, must be made traceable to one single initiating event, such as the first day of ovarian stimulation or the collection of oocytes, even if that event took place several years earlier. In failed cases or when frozen material was lost or destroyed or transported, negative outcome events should be recorded in order to avoid overestimation of treatment efficacy. To all stakeholders, both surveillance and vigilance in ART are crucial steps towards better quality control and full transparency.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app